## ADBE: Adobe Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.00 indicates fundamental undervaluation. Quality metrics strong (ROE 53%, ROA 18%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($330.83)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Oracle, Adobe and Broadcom fall premarket; Eli Lilly gains**
- Source: Investing.com | 20251211T130747 | Neutral | Relevance: 100%
-  U.S. stock futures pulled back Thursday following the Federal Reserve's expected rate cut and as the earnings season concludes. Oracle slumped on a missed forecast, while Eli Lilly rose on strong obesity drug trial results, contrasting with declines for Adobe and Broadcom ahead of its earnings. Other movers included Gemini Space Station soaring on CFTC approval, Oxford Industries falling due to a cut forecast, and Ciena gaining on exceeding expectations.

**2. Adobe’s (ADBE) Turnaround Story Gains Shape, but Stifel Still Sees Uncertainty**
- Source: Yahoo! Finance Canada | 20251209T202720 | Neutral | Relevance: 100%
- Stifel cut its price target on Adobe (ADBE) to $450 from $480 but maintained a "Buy" rating, acknowledging the company's generative AI efforts while flagging concerns about AI disrupting creative departments. Meanwhile, TD Cowen reiterated a "Hold" rating with a $420 price target, citing AI competition and slowing growth, suggesting investors await more clarity on AI's impact on Adobe's business model. Adobe is scheduled to release its fiscal fourth-quarter 2025 results on December 10th.

**3. Adobe’s AI-driven earnings beat is not enough to boost the stock**
- Source: MarketWatch | 20251210T222400 | Neutral | Relevance: 99%
- Adobe's stock saw a fractional increase after its fiscal fourth-quarter earnings report, but this was not enough to counter bleak market sentiment. Despite reporting record fiscal 2025 results, attributed to the global adoption of its AI tools, the shares dipped in extended trading, reflecting concerns that the company isn't moving fast enough in the AI space. Adobe's shares are down over 22% for the year.

**4. Adobe (ADBE) Will Report Q4 Earnings Tomorrow. Here Is What to Expect**
- Source: TipRanks | 20251209T050825 | Neutral | Relevance: 99%
- Adobe (ADBE) is set to report its fourth-quarter fiscal 2025 results on December 10, with analysts expecting earnings of $5.40 per share and revenues of $6.11 billion. The stock is down over 24% this year due to AI competition and cautious guidance, but investors hope the Q4 results will show progress in AI monetization. Analysts have varied views, with some maintaining ratings while others adjusted price targets, and options traders anticipate a 7.58% move post-earnings.

**5. Creative Software Leader Adobe Tops Q4 Targets, Moves The Chains**
- Source: Investor's Business Daily | 20251211T110754 | Bullish | Relevance: 99%
-  Adobe (ADBE) exceeded Wall Street's expectations for its fiscal fourth quarter and provided strong guidance for the current period, though its stock wavered in late trading. The company reported adjusted earnings of $5.50 per share on sales of $6.19 billion for the quarter ending November 28th. This positive performance comes amidst discussions about the impact of AI on tech companies, with Adobe recently making significant moves in generative AI offerings.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 9)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Jefferies | $500 | $590 | -15% |
| 2025-12-11 | DA Davidson | $500 | $500 | 0% |
| 2025-12-11 | Oppenheimer | $430 | $460 | -7% |
| 2025-12-11 | TD Cowen | $400 | $420 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Jefferies | main | Buy |
| 2025-12-11 | DA Davidson | main | Buy |
| 2025-12-11 | Oppenheimer | main | Outperform |
| 2025-12-11 | TD Cowen | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 10 ($0.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+0.8%)
- Blackrock Inc.: 9.7% (+0.9%)
- State Street Corpora: 4.9% (+1.7%)
- Geode Capital Manage: 2.7% (+0.3%)
- Morgan Stanley: 1.7% (-6.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.00 suggests fair value with growth premium. Quality metrics strong (ROE 53%, ROA 18%, margin 30%). Balance sheet: $2.1B free cash flow. Analyst sentiment negative (9 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $148.7B |
| Beta | 1.00 |
| 52W Range | $311.59 - $494.00 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 13.4 |
| Current P/E | 14.9 |
| YoY Growth | 11.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.6% over 5 days). Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 72nd percentile. MRS_5 at 1.7% confirms short-term momentum alignment. AM_20 at 6.7% shows strong absolute momentum above own 20MA. Outperforming sector by 3.3pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (3.79), confirming momentum. Elevated volume (1.8x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.43% (CS: 73) | Strong |
| RSI_14 | 63.4 | Neutral |
| MACD Histogram | 3.79 | Bullish |
| vs SMA20 | 1.067x | Above |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 0.953x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $350.43
- **Stop Loss:** $330.83 (5.6% risk)
- **Target:** $389.63 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 70
- **Position Value:** $24,530.10
- **Portfolio %:** 24.53%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.18 | $5.31 | +2.5% |
| 2025Q2 | $4.97 | $5.06 | +1.7% |
| 2025Q1 | $4.97 | $5.08 | +2.2% |
| 2024Q4 | $4.67 | $4.81 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*